DRUG PRICING OUTRAGE

Where is Teddy Roosevelt when we need him?*

Stung by criticism of its plan to charge a whopping $89,000 a year in the U.S. for a muscular dystrophy drug that costs less than $1,500 elsewhere, Marathon Pharmaceuticals on Monday said it was "pausing" that rollout for an unspecified amount of time.
.................................................................
Marathon's announcement came hours after the company was blasted by two members of Congress for its "outrageous plan" to charge $89,000 per year for Emflaza, its brand name for deflazacort, a corticosteroid that received regulatory approval for U.S. sales last week. Deflazacort used to treat Duchenne muscular dystrophy, a progressive muscular degeneration condition that afflicts fewer than 15,000 children, mostly boys.**

So the drumbeat of outrages drug price increases continue.

* http://stopcontinentaldrift.blogspot.com/2016/08/where-is-teddy-roosevelt-when-we-need.html
http://www.cnbc.com/2017/02/13/marathon-pharmaceuticals-criticized-for-outrageous-pricing-of-drug.html
** http://stopcontinentaldrift.blogspot.com/2016/08/where-is-teddy-roosevelt-when-we-need.html